Evidence map›Paper›PMID 37512312›Full record

ReviewMaterials (Basel, Switzerland)2023

A Review on Multiple I-III-VI Quantum Dots: Preparation and Enhanced Luminescence Properties.

Ting Chen, Yuanhong Chen, Youpeng Li, Mengbiao Liang, Wenkui Wu, Yude Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Preparation of CuInSMethods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Synthesis of AgInSDiscover oncology · 2025
    Article
  3. Review
  4. A Review of in vivo Toxicity of Quantum Dots in Animal Models.International journal of nanomedicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting ChenInstitute of Materials Science & Devices, Suzhou University of Science and Technology, Suzhou 215009, China.ORCID 0000-0002-3153-2996
Yuanhong ChenInstitute of Materials Science & Devices, Suzhou University of Science and Technology, Suzhou 215009, China.
Youpeng LiInstitute of Materials Science & Devices, Suzhou University of Science and Technology, Suzhou 215009, China.
Mengbiao LiangInstitute of Materials Science & Devices, Suzhou University of Science and Technology, Suzhou 215009, China.
Wenkui WuInstitute of Materials Science & Devices, Suzhou University of Science and Technology, Suzhou 215009, China.
Yude WangNational Center for International Research on Photoelectric and Energy Materials, School of Materials and Energy, Yunnan University, Kunming 650504, China.ORCID 0000-0001-5152-2667

Funding

National Natural Science Foundation of China Ting Chen 52062019the Qinglan Project of Jiangsu Province Ting Chen
6 · The paper itself

Abstract

I-III-VI type QDs have unique optoelectronic properties such as low toxicity, tunable bandgaps, large Stokes shifts and a long photoluminescence lifetime, and their emission range can be continuously tuned in the visible to near-infrared light region by changing their chemical composition. Moreover, they can avoid the use of heavy metal elements such as Cd, Hg and Pb and highly toxic anions, i.e., Se, Te, P and As. These advantages make them promising candidates to replace traditional binary QDs in applications such as light-emitting diodes, solar cells, photodetectors, bioimaging fields, etc. Compared with binary QDs, multiple QDs contain many different types of metal ions. Therefore, the problem of different reaction rates between the metal ions arises, causing more defects inside the crystal and poor fluorescence properties of QDs, which can be effectively improved by doping metal ions (Zn

Indexed as

metal ion dopingmultiple quantum dotsoptoelectronicsurface coatingwhite light emitting diodes

Identifiers

PMID37512312
PMCPMC10384050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.